BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• FDA

  Cephalon, Inc. Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin’s Lymphoma

  November 3, 2008

   · 

  7 min read
• Pharm Country

  PuriCore Notification of PDMR Interest-Option Award

  November 3, 2008

   · 

  1 min read
• Business

  DUSA Pharmaceuticals Reports Third Quarter 2008 Corporate Highlights and Financial Results

  November 3, 2008

   · 

  1 min read
• Genetown

  NxStage Medical, Inc. Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy

  November 3, 2008

   · 

  5 min read
• Drug Development

  GlobeImmune, Inc. Hepatitis C Therapeutic Vaccine, GI-5005, Doubles Viral Clearance and Increases RVR Rates in Phase 2 Clinical Trial

  November 3, 2008

   · 

  1 min read
• ONI BioPharma Offers Investor Update. Topics Include: (1) Appeal of AMEX Delisting Decision, (2) Operational Update and (3) Announcement of Investor Conference Call

  November 3, 2008

   · 

  1 min read
• Drug Development

  Mpex Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD

  November 3, 2008

   · 

  4 min read
• Transparency Notification Of UCB Group’s Reference Shareholders

  November 3, 2008

   · 

  1 min read
• UCB Group Release: Transparency Notification of Wellington Management Company LLP

  November 3, 2008

   · 

  1 min read
• Deals

  Bioheart, Inc. Announces Termination of Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.

  November 3, 2008

   · 

  1 min read